AbbVie Receivables 2012-2026 | ABBV

AbbVie receivables for the quarter ending March 31, 2026 were $12.769B, a 11.31% increase year-over-year.

  • AbbVie receivables for 2024 were $10.919B, a 2.12% decline from 2023.
  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.

AbbVie Receivables 2012-2026 | ABBV

  • AbbVie receivables for 2024 were $10.919B, a 2.12% decline from 2023.
  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B